XILIO Trademark

Trademark Overview

On Monday, February 3, 2020, a trademark application was filed for XILIO with the United States Patent and Trademark Office. The USPTO has given the XILIO trademark a serial number of 88783246. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Tuesday, December 6, 2022. This trademark is owned by Akrevia Therapeutics, Inc.. The XILIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of cancer, all of the foregoing excluding pharmaceutical products for sleep disorders, central nervous disorders (other than cancers of the central nervous system), and neurological disorders (other than cancers of the neurological system)
xilio

General Information

Serial Number88783246
Word MarkXILIO
Filing DateMonday, February 3, 2020
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateTuesday, December 6, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 2, 2020

Trademark Statements

Goods and ServicesPharmaceutical products for the treatment of cancer, all of the foregoing excluding pharmaceutical products for sleep disorders, central nervous disorders (other than cancers of the central nervous system), and neurological disorders (other than cancers of the neurological system)

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateTuesday, December 6, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameXILIO DEVELOPMENT, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameAkrevia Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameAkrevia Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Tuesday, December 6, 2022ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Tuesday, December 6, 2022ABANDONMENT - AFTER PUBLICATION
Monday, December 5, 2022TEAS EXPRESS ABANDONMENT RECEIVED
Friday, May 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 19, 2022SOU EXTENSION 3 GRANTED
Wednesday, May 11, 2022SOU EXTENSION 3 FILED
Wednesday, May 11, 2022TEAS EXTENSION RECEIVED
Thursday, November 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 23, 2021SOU EXTENSION 2 GRANTED
Tuesday, November 23, 2021SOU EXTENSION 2 FILED
Tuesday, November 23, 2021TEAS EXTENSION RECEIVED
Wednesday, June 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 7, 2021SOU EXTENSION 1 GRANTED
Monday, June 7, 2021SOU EXTENSION 1 FILED
Monday, June 7, 2021TEAS EXTENSION RECEIVED
Wednesday, May 19, 2021CORRECTED NOA E-MAILED
Tuesday, May 18, 2021DIVISIONAL PROCESSING COMPLETE
Tuesday, April 6, 2021DIVISIONAL REQUEST RECEIVED
Monday, April 26, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 6, 2021TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, December 8, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 25, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, October 28, 2020CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, October 27, 2020ASSIGNED TO PETITION STAFF
Wednesday, October 14, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sunday, October 11, 2020EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Wednesday, September 16, 2020TEAS POST PUBLICATION AMENDMENT RECEIVED
Monday, June 29, 2020EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, June 2, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 2, 2020PUBLISHED FOR OPPOSITION
Wednesday, May 13, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 24, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 22, 2020ASSIGNED TO EXAMINER
Thursday, February 6, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 6, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

xilio disorders other nervous than cancers neurological system central pharmaceutical products